Analysts Set Revvity, Inc. (NYSE:RVTY) Price Target at $128.79

Revvity, Inc. (NYSE:RVTY) has been given an average recommendation of “Moderate Buy” by the sixteen research firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $128.79.

A number of brokerages recently issued reports on RVTY. Bank of America lifted their target price on Revvity from $118.00 to $127.00 and gave the stock a “neutral” rating in a report on Tuesday, July 30th. JPMorgan Chase & Co. upped their price objective on shares of Revvity from $105.00 to $120.00 and gave the company a “neutral” rating in a research note on Tuesday, July 30th. Wells Fargo & Company initiated coverage on shares of Revvity in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $130.00 target price for the company. Leerink Partnrs upgraded shares of Revvity to a “strong-buy” rating in a report on Monday, July 8th. Finally, Jefferies Financial Group raised their price objective on shares of Revvity from $115.00 to $125.00 and gave the stock a “hold” rating in a research note on Monday, July 29th.

Revvity Trading Up 2.1 %

Shares of NYSE:RVTY opened at $121.04 on Friday. The stock has a market capitalization of $14.93 billion, a price-to-earnings ratio of 87.71, a PEG ratio of 3.27 and a beta of 1.06. Revvity has a 1-year low of $82.17 and a 1-year high of $128.15. The company has a 50 day moving average price of $121.39 and a 200 day moving average price of $114.11. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.98 and a current ratio of 2.27.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 7th. Investors of record on Friday, January 17th will be paid a $0.07 dividend. The ex-dividend date is Friday, January 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.23%. Revvity’s payout ratio is 20.29%.

Insider Activity at Revvity

In related news, insider Tajinder S. Vohra sold 2,153 shares of Revvity stock in a transaction on Monday, October 7th. The shares were sold at an average price of $122.09, for a total value of $262,859.77. Following the completion of the sale, the insider now owns 23,960 shares of the company’s stock, valued at approximately $2,925,276.40. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Revvity news, insider Tajinder S. Vohra sold 2,154 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $121.73, for a total transaction of $262,206.42. Following the completion of the sale, the insider now owns 19,652 shares of the company’s stock, valued at $2,392,237.96. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Tajinder S. Vohra sold 2,153 shares of Revvity stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $122.09, for a total transaction of $262,859.77. Following the completion of the transaction, the insider now directly owns 23,960 shares in the company, valued at approximately $2,925,276.40. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,807 shares of company stock valued at $937,576. 0.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Revvity

Large investors have recently modified their holdings of the company. Rothschild Investment LLC acquired a new position in Revvity during the 2nd quarter worth $25,000. EverSource Wealth Advisors LLC lifted its position in shares of Revvity by 74.2% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 392 shares of the company’s stock worth $41,000 after purchasing an additional 167 shares during the last quarter. Family Firm Inc. bought a new stake in Revvity during the 2nd quarter valued at approximately $43,000. Fairfield Financial Advisors LTD acquired a new stake in Revvity in the 2nd quarter valued at approximately $43,000. Finally, EntryPoint Capital LLC acquired a new stake in Revvity in the 1st quarter valued at approximately $48,000. 86.65% of the stock is owned by institutional investors.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.